# A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

> **NCT00394771** · PHASE2 · COMPLETED · sponsor: **Duramed Research** · enrollment: 567 (actual)

## Conditions studied

- Breakthrough Bleeding

## Interventions

- **DRUG:** DR-1031
- **DRUG:** Seasonale®
- **DRUG:** Portia®

## Key facts

- **NCT ID:** NCT00394771
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 567 (ACTUAL)
- **Last updated:** 2013-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394771, "A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00394771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*